Massive Bio As

Home
United States
Dallas, TX
Massive Bio As

Empowering cancer patients globally through our AI-based, clinical trial matching platform, always 100% free. Providing options & hope.

06/03/2026

Early detection only delivers on its promise when it opens doors to the best available care.

5-year survival rates for lung cancer rise from 9% when caught late — to 64% when caught early. But most high-risk patients still never reach a clinical trial.

Massive Bio and Optellum are working to change that. Our new collaboration connects Optellum's FDA-cleared AI, which identifies high-risk lung cancer patients before a formal diagnosis is confirmed, to Massive Bio's clinical trial matching platform, so patients are considered for active trials at exactly the right moment in their care journey.

Earlier identification. Smarter matching. No delays.

https://massivebio.com/massive-bio-optellum-nsclc-clinical-trial-access/?utm_source=facebook&utm_medium=organic&utm_campaign=optellum-partnership&utm_content=announcement-post

06/01/2026

There are questions cancer patients carry that don't always get asked out loud. Fear of being treated like a number. Not knowing if their doctor has seen every option. Wondering if clinical trials are even safe to consider.

Every Monday, we're making space for those questions. Honestly, without the medical jargon.

This week we cover four of the most common ones we hear from patients and their families. Swipe through and share with someone who might need to see this.

If something resonated or you have a question of your own, leave it in the comments. We read every one.

Explore clinical trials: massivebio.com/explore-clinical-trials

05/29/2026

Finding the right clinical trial can change everything for a cancer patient. But for too many, that connection never happens.

Massive Bio has partnered with TOUCH, The Black Breast Cancer Alliance and Navigating Trials to change that. Our AI-powered matching is now embedded directly into the communities patients already trust, so no one misses a trial that could matter.

Read the full announcement: https://massivebio.com/massive-bio-touch-bbca-navigating-trials?utm_source=facebook&utm_medium=organic&utm_campaign=touch-bbca-navigating-trials-pr

05/21/2026

We're expanding access to oncology clinical trials for underserved communities, with privacy built in from the start.

Massive Bio has deployed its AI-powered pre-screening capabilities through BeeKeeperAI's EscrowAI® platform, leveraging federated confidential computing to match cancer patients to clinical trials without ever moving their sensitive data outside the healthcare provider's environment.

The program initially focuses on the Atlanta, Georgia region, working to reach historically underrepresented patient populations who may otherwise never learn about trials they qualify for.

This is what equitable, scalable clinical research looks like: AI traveling to the data, not the other way around.

🔗 Read the full announcement: https://massivebio.com/massive-bio-beekeeperai-collaboration?utm_source=facebook&utm_medium=organic&utm_campaign=massive-bio-beekeeperai-collaboration

05/20/2026

Today, May 20, is International Clinical Trials Day.

Clinical trials are how medicine moves forward. But for too long, finding the right trial has been one of the hardest parts of a cancer diagnosis.

At Massive Bio, we exist to change that. Our AI has matched over 190,000 patients to clinical trials across 17 countries, so that geography, complexity, and time never stand between a patient and a potentially life-changing option.

Every match matters. Every trial matters. Every patient matters.

05/10/2026

Happy Mother's Day! 💙

To all the moms who loved fiercely, sacrificed quietly, and showed up every single day, today is for you.

At Massive Bio, everything we do comes back to keeping families together. Connecting cancer patients to the right clinical trials means more time, more hope, and more moments that matter.

Wishing a beautiful day to every mother and every family celebrating today.

04/28/2026

Massive Bio is collaborating with OpenAI to expand global access to clinical trials. 🌍

Through our collaboration with OpenAI, we're enabling real-time trial parameterization and free pre-screening services in high-population regions, ensuring that life-changing opportunities are available to patients everywhere, not just those near major research centers.

This is what AI-driven precision oncology looks like in practice: breaking down the barriers that have long kept underserved patients from accessing the trials that could change their lives.

Read the full announcement → https://massivebio.com/massive-bio-expands-global-access-to-clinical-trials-through-ai-powered-parameterization-and-pre-screening-with-openai/?utm_source=facebook&utm_medium=organic&utm_campaign=openai-partnership&utm_content=announcement-post

04/24/2026

The gap between cancer patients and clinical trials has always been an access problem.

On April 28, we are announcing a collaboration that changes this at a scale never seen before.

Can you guess who we are collaborating with? 👇

04/15/2026

Big news. Massive Bio has officially earned the DiMe Seal and joined the CMS Medicare App Library.

This means our platform has been independently verified for clinical evidence, privacy, usability, and security, and is now accessible to over 68 million Medicare beneficiaries through a federally recognized channel.

For every cancer patient searching for the right trial, this is one more reason to trust the journey with us.

04/01/2026

We have been nominated at the 30th Annual Webby Awards in the AI - Healthcare and Life Sciences category, placing us among the top 11% of over 13,000 entries worldwide. 🏆

The People's Voice Award is decided by public votes. Voting is open until April 16th. 🗓️

Your vote helps more cancer patients access clinical trials worldwide. 🌍

Vote here: https://vote.webbyawards.com/PublicVoting #/2026/ai/ai-experiences-applications/healthcare-life-sciences

Address

Dallas, TX
75202

Website

http://www.massivebio.com/

Alerts

Be the first to know and let us send you an email when Massive Bio As posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your business to be the top-listed Business in Dallas?